+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Changes in the immunological parameters after a single dose of forphenicinol, a new small molecular immunomodifier



Changes in the immunological parameters after a single dose of forphenicinol, a new small molecular immunomodifier



Tohoku Journal of Experimental Medicine 146(4): 419-427



Forphenicinol [L-2-(3-hydroxy-4-hydroxymethyl-phenyl) glycine, M.W. 197.19] is a derivative of forphenicine, an inhibitor of alkaline phosphatase discovered by Umezawa. In order to find an optimal dose, a single dose of the drug ranging from 10 to 600 mg per body was orally administered to a total of 55 patients (36 cancer, 13 tuberculosis, and 6 others). The possible changes in the percentages of the peripheral T and B lymphocytes, natural killer (NK) activity, and the proliferative response to phytohemaglutinin (PHA) were studied as immunological parameters. A significant effect of forphenicinol was demonstrated in restoring the normal proportion of T and B cells, especially in those who had 'low'-T and/or 'high'-B before administration of the drug. No difference was found between cancer and tuberculosis. The mean percentage of T cells increased from the low initial level of 68.0 to 75.6 in cancer (n = 12, p less than 0.05) or from 63.1 to 78.5 in tuberculosis (n = 7, p less than 0.05), while that of B cells decreased from the high initial level of 34.6 to 26.9 in cancer (n = 7) or from 34.9 to 14.3 in tuberculosis (n = 6, p less than 0.025). The effect of a single dose of the drug tended to disappear by day 8, a peak response being found on day 3 in most cases. With respect to this parameter, an optimal dose was found in a range from 60 to 100 mg. Forphenicinol was rather inhibitory on the NK activity, while it exerted diverse effect on the lymphocyte proliferation. No evidence of adverse effect was observed.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 004914349

Download citation: RISBibTeXText

PMID: 4071537

DOI: 10.1620/tjem.146.419


Related references

Effect of forphenicinol a small molecular immunomodifier on growth of a syngeneic guinea pig hepatoma and a study of its mechanisms. Uicc (Union Internationale Contre Le Cancer, International Union Against Cancer) 14th International Cancer Congress, Budapest, Hungary, Aug 21-27, Abstracts, Lectures, Symposia And Free Communications, Vols 1, 2, 3, Late Abstracts, And Register Xvi+479p (Vol 1); Xvi+298p (Vol 2); Xvi+531p (Vol 3); 15p (Late Abstracts); 40p (Register) S Karger Ag: Basel, Switzerland; New York, N Y , Usa; Akademiai Kiado: Budapest, Hungary Paper 659, 1986

Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors. Cancer Treatment Reports 69(3): 285-291, 1985

Effect of forphenicinol, a low molecular weight immunomodifier, on the growth of and the immune responses to murine lymphoma EL4. Journal of Biological Response Modifiers 6(1): 35-43, 1987

Protective effect of forphenicinol, a low molecular weight immunomodifier, against infection with Pseudomonas aeruginosa in mice and its mechanisms. Journal of Antibiotics 40(4): 547-554, 1987

Antitumor effect of forphenicinol, a low molecular weight immunomodifier, on murine transplantable tumors and microbial infections. Journal of Antibiotics 35(8): 1049-1054, 1982

Antitumor effect of forphenicinol, a low molecular weight immunomodifier, in combination with surgery on Meth A fibrosarcoma, Lewis lung carcinoma, and adenocarcinoma 755. Journal of Antibiotics 39(4): 564-568, 1986

Clinical and immunological studies on forphenicinol, a low molecular weight immunomodulator, in chronic respiratory infections. Kansenshogaku Zasshi. Journal of the Japanese Association for Infectious Diseases 59(10): 996-1004, 1985

Fundamental and clinical studies on forphenicinol, a small-molecular immunomodulator. Japanese Journal of Antibiotics 37(2): 185-197, 1984

Imbalance of T cell subsets in cancer patients and its modification with bestatin, a small molecular immunomodifier. Tohoku Journal of Experimental Medicine 147(2): 125-133, 1985

Effect of a single dose of levamisole on selected immunological parameters in patients. Polski Tygodnik Lekarski 38(1): 31-34, 1983

Giardiasis. Functional, immunological and histological study of the small bowel. Therapeutic trial with a single dose of tinidazole. Arquivos de Gastroenterologia 24(2): 102-112, 1987

Serological Responses In Man To A Single Small Dose Of Cholera Vaccine With Special Reference To The Lack Of Influence Of Abo Blood Group On Natural Antibody Or Immunological Responsiveness. Bulletin of the Johns Hopkins Hospital 116: 152-160, 1965

In vivo assessment of dose volume and dose gradient effects on the tolerance dose of small liver volumes after single-fraction high-dose-rate 192Ir irradiation. Radiation Research 172(5): 598-606, 2009

Fundamental study on a low molecular immunomodifier ubenimex. Takeuchi, T , K Nitta And N Tanaka (Ed ) Gann Monograph on Cancer Research, No 36 Antitumor Natural Products: Basic And Clinical Research Xviii+206p Japanese Cancer Association: Tokyo, Japan; Taylor And Francis Ltd : London, England, Uk; Bristol, Pennsylvania, Usa Illus 147-156, 1989

Synthesis of DL-forphenicinol, a lower molecular weight immunomodulator. Chinese Journal of Pharmaceuticals 23(6): 244-246, 1992